ARTICLE
21 January 2026

FDA's New AI And Wearables Guidance

Paul Gadiock joins Erin Fuller in the Breakroom to discuss the recent FDA guidance on clinical decision support (CDS) software and general wellness products, and the tone this sets for the future of digital health product regulation.
United States Food, Drugs, Healthcare, Life Sciences

Paul Gadiock joins Erin Fuller in the Breakroom to discuss the recent FDA guidance on clinical decision support (CDS) software and general wellness products, and the tone this sets for the future of digital health product regulation.

Read more about the new guidance in our client alert.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More